{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:07Z","timestamp":1793727907814,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myxofibrosarcoma (MFS) is a rare, aggressive soft tissue sarcoma with a high local recurrence rate, mostly affecting elderly patients. Sarcopenia, the progressive loss of skeletal muscle mass, and its CT-related assessment is an emerging prognostic factor in cancer care, yet its role in MFS remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective longitudinal study of 55 patients with high-grade MFS who underwent surgical resection and had at least two CT scans between 2010 and 2024 with a mean scan-interval of 13.2\u2009\u00b1\u20092.1 months. CT-derived morphometric parameters, including skeletal muscle index (SMI), paraspinal muscle index (PSMI), psoas muscle index (PMI), skeletal muscle density (SMD), and visceral adipose tissue (VAT), were measured at the L3 vertebral level. We analyzed changes in body composition over time and their associations with chemotherapy, radiotherapy, tumor recurrence, postoperative complications, survival and functional status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SMI, PSMI, PMI, and VAT declined significantly during the disease course, while SMD remained stable. Chemotherapy and local tumor recurrence were associated with greater muscle and fat loss, whereas radiotherapy showed no significant impact. A\u2009\u2265\u200915% decrease in SMI was associated with shorter median overall survival (32 vs. 80 months,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). Although pre-treatment sarcopenia did not affect survival it was linked to longer hospital stays (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) and increased risk for postoperative wound infections (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CT-based body composition analysis offers a practical approach for risk stratification in MFS patients. Routine assessment of sarcopenia using existing imaging can help identify those at higher risk for poor survival, extended hospitalization, and wound complications. Incorporating these metrics into preoperative planning may guide early supportive measures, such as nutritional and wound care interventions. Prospective multicenter studies are needed to confirm these findings and assess whether targeted strategies can reduce sarcopenia-related morbidity and improve outcomes in this rare sarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04069-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:48:13Z","timestamp":1761666493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic and clinical implications of CT-morphometric sarcopenia in adult myxofibrosarcoma patients: a longitudinal analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Julian","family":"Kylies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonja","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Brauneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana K.","family":"Striefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Priemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"4069_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.soc.2022.03.006","volume":"31","author":"AM Crago","year":"2022","unstructured":"Crago AM, et al. Management of myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Surg Oncol Clin N Am. 2022;31(3):419\u201330.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"4069_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.soc.2016.05.008","volume":"25","author":"CL Roland","year":"2016","unstructured":"Roland CL, et al. Myxofibrosarcoma. Surg Oncol Clin N Am. 2016;25(4):775\u201388.","journal-title":"Surg Oncol Clin N Am"},{"key":"4069_CR3","doi-asserted-by":"publisher","first-page":"175883592210939","DOI":"10.1177\/17588359221093973","volume":"14","author":"S Vanni","year":"2022","unstructured":"Vanni S, et al. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives. Ther Adv Med Oncol. 2022;14:17588359221093972.","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"4069_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000507334","volume":"43","author":"A Sambri","year":"2020","unstructured":"Sambri A, et al. The biology of Myxofibrosarcoma: state of the art and future perspectives. Oncol Res Treat. 2020;43(6):314\u201322.","journal-title":"Oncol Res Treat"},{"key":"4069_CR5","doi-asserted-by":"publisher","unstructured":"Nishio J, Nakayama S. Biology and management of high-grade myxofibrosarcoma: state of the art and future perspectives. Diagnostics (Basel). 2023;7(3):281\u20138. https:\/\/doi.org\/10.3390\/diagnostics13193022.","DOI":"10.3390\/diagnostics13193022"},{"issue":"1","key":"4069_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"key":"4069_CR7","doi-asserted-by":"publisher","unstructured":"Meza-Valderrama D, et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;22(6):602\u20139. https:\/\/doi.org\/10.3390\/nu13030761.","DOI":"10.3390\/nu13030761"},{"key":"4069_CR8","doi-asserted-by":"publisher","unstructured":"Bossi P, et al. The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;11(1):5. https:\/\/doi.org\/10.3390\/nu13061980.","DOI":"10.3390\/nu13061980"},{"issue":"19","key":"4069_CR9","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1200\/JCO.21.00102","volume":"39","author":"GR Williams","year":"2021","unstructured":"Williams GR, et al. Sarcopenia in the older adult with cancer. J Clin Oncol. 2021;39(19):2068\u201378.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4069_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290\u20138.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"4069_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.ijo.0800875","volume":"23","author":"DB Allison","year":"1999","unstructured":"Allison DB, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23(6):603\u201311.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"4069_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00779-2","volume":"13","author":"H Mian","year":"2023","unstructured":"Mian H, et al. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review. Blood Cancer J. 2023;13(1):6.","journal-title":"Blood Cancer J"},{"issue":"3","key":"4069_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jgo.2018.10.009","volume":"10","author":"GR Williams","year":"2019","unstructured":"Williams GR, et al. Sarcopenia & aging in cancer. J Geriatr Oncol. 2019;10(3):374\u20137.","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"4069_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","volume":"11","author":"S Peixoto da Silva","year":"2020","unstructured":"Peixoto da Silva S, et al. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;11(3):619\u201335.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"4069_CR15","first-page":"37","volume":"25","author":"G Bahat","year":"2022","unstructured":"Bahat G, Erdo\u011fan T, \u0130lhan B. SARC-f and other screening tests for sarcopenia. Curr Opin Clin Nutr Metab Care. 2022;25(1):37\u201342.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4069_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.avsg.2017.08.002","volume":"47","author":"MM Chowdhury","year":"2018","unstructured":"Chowdhury MM, et al. Morphometric assessment as a predictor of outcome in older vascular surgery patients. Ann Vasc Surg. 2018;47:90\u20137.","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"4069_CR17","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","volume":"47","author":"V Chianca","year":"2022","unstructured":"Chianca V, et al. Sarcopenia: imaging assessment and clinical application. Abdom Radiol (NY). 2022;47(9):3205\u201316.","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"4069_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00256-021-03951-0","volume":"51","author":"O Laur","year":"2022","unstructured":"Laur O, et al. Computed tomography-based body composition profile as a screening tool for geriatric frailty detection. Skeletal Radiol. 2022;51(7):1371\u201380.","journal-title":"Skeletal Radiol"},{"issue":"7","key":"4069_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jgo.2022.03.008","volume":"13","author":"Q Sun","year":"2022","unstructured":"Sun Q, et al. Sarcopenia among older patients with cancer: a scoping review of the literature. J Geriatr Oncol. 2022;13(7):924\u201334.","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"4069_CR20","first-page":"410","volume":"27","author":"F Bozzetti","year":"2024","unstructured":"Bozzetti F. Age-related and cancer-related sarcopenia: is there a difference? Curr Opin Clin Nutr Metab Care. 2024;27(5):410\u20138.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"4069_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10522-021-09932-z","volume":"22","author":"A Moreira-Pais","year":"2021","unstructured":"Moreira-Pais A, et al. Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging. Biogerontology. 2021;22(5):459\u201377.","journal-title":"Biogerontology"},{"issue":"4","key":"4069_CR22","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, et al. Imaging of sarcopenia: old evidence and new insights. Eur Radiol. 2020;30(4):2199\u2013208.","journal-title":"Eur Radiol"},{"key":"4069_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110663","volume":"203","author":"AJ Vickers","year":"2025","unstructured":"Vickers AJ, et al. The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: a systematic review. Radiother Oncol. 2025;203:110663.","journal-title":"Radiother Oncol"},{"issue":"1","key":"4069_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11423-y","volume":"23","author":"MEH \u015eahin","year":"2023","unstructured":"\u015eahin MEH, et al. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer. BMC Cancer. 2023;23(1):911.","journal-title":"BMC Cancer"},{"issue":"2","key":"4069_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1200\/JCO.2017.74.9598","volume":"36","author":"ATJ Lee","year":"2018","unstructured":"Lee ATJ, et al. Clinical and molecular spectrum of liposarcoma. J Clin Oncol. 2018;36(2):151\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4069_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41416-022-02099-5","volume":"128","author":"J McGovern","year":"2023","unstructured":"McGovern J, et al. Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer. Br J Cancer. 2023;128(5):760\u20135.","journal-title":"Br J Cancer"},{"issue":"8","key":"4069_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161125","volume":"11","author":"EY Kim","year":"2016","unstructured":"Kim EY, et al. The relationship between sarcopenia and systemic inflammatory response for cancer cachexia in small cell lung cancer. PLoS ONE. 2016;11(8):e0161125.","journal-title":"PLoS ONE"},{"issue":"4","key":"4069_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ags3.12663","volume":"7","author":"Y Takano","year":"2023","unstructured":"Takano Y, et al. Prognostic significance of osteosarcopenia in older adults with colorectal cancer. Ann Gastroenterol Surg. 2023;7(4):637\u201344.","journal-title":"Ann Gastroenterol Surg"},{"issue":"4","key":"4069_CR29","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.21873\/invivo.13602","volume":"38","author":"S Lavalle","year":"2024","unstructured":"Lavalle S, et al. Unveiling the intricate dance: how cancer orchestrates muscle wasting and sarcopenia. In Vivo. 2024;38(4):1520\u20139.","journal-title":"In Vivo"},{"issue":"39","key":"4069_CR30","doi-asserted-by":"publisher","first-page":"25714","DOI":"10.18632\/oncotarget.25394","volume":"9","author":"F Mazzuca","year":"2018","unstructured":"Mazzuca F, et al. Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget. 2018;9(39):25714\u201322.","journal-title":"Oncotarget"},{"issue":"1","key":"4069_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09443-1","volume":"22","author":"M Amitani","year":"2022","unstructured":"Amitani M, et al. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer. 2022;22(1):327.","journal-title":"BMC Cancer"},{"issue":"12","key":"4069_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10151-023-02812-3","volume":"27","author":"L Traeger","year":"2023","unstructured":"Traeger L, et al. The impact of preoperative sarcopenia on postoperative ileus following colorectal cancer surgery. Tech Coloproctol. 2023;27(12):1265\u201374.","journal-title":"Tech Coloproctol"},{"issue":"7","key":"4069_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jtho.2018.04.035","volume":"13","author":"R Nakamura","year":"2018","unstructured":"Nakamura R, et al. Sarcopenia in resected NSCLC: effect on postoperative outcomes. J Thorac Oncol. 2018;13(7):895\u2013903.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4069_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00595-016-1357-x","volume":"47","author":"H Fujikawa","year":"2017","unstructured":"Fujikawa H, et al. Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis. Surg Today. 2017;47(1):92\u20138.","journal-title":"Surg Today"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04069-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:02:24Z","timestamp":1761706944000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4069"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04069-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee of the Hamburg Medical Association, ID: 2025\u2013300576-WF, Consent to participate not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publish this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}